Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Coulibaly, Boubacar [VerfasserIn]   i
 Pritsch, Michael [VerfasserIn]   i
 Bountogo, Mamadou [VerfasserIn]   i
 Meissner, Peter [VerfasserIn]   i
 Nebié, Eric [VerfasserIn]   i
 Klose, Christina [VerfasserIn]   i
 Kieser, Meinhard [VerfasserIn]   i
 Berens-Riha, Nicole [VerfasserIn]   i
 Wieser, Andreas [VerfasserIn]   i
 Sirima, Sodiomon [VerfasserIn]   i
 Breitkreutz, Jörg [VerfasserIn]   i
 Schirmer, Rolf Heiner [VerfasserIn]   i
 Sié, Ali [VerfasserIn]   i
 Mockenhaupt, Frank Peter [VerfasserIn]   i
 Drakeley, Chris [VerfasserIn]   i
 Bousema, Teun [VerfasserIn]   i
 Müller, Olaf [VerfasserIn]   i
Titel:Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children
Titelzusatz:a randomized controlled trial in Burkina Faso
Verf.angabe:Boubacar Coulibaly, Michael Pritsch, Mamadou Bountogo, Peter E. Meissner, Eric Nebié, Christina Klose, Meinhard Kieser, Nicole Berens-Riha, Andreas Wieser, Sodiomon B. Sirima, Jörg Breitkreutz, R. Heiner Schirmer, Ali Sié, Frank P. Mockenhaupt, Chris Drakeley, Teun Bousema, and Olaf Müller
E-Jahr:2015
Jahr:1 March 2015
Umfang:9 S.
Fussnoten:Gesehen am 10.12.2020 ; Published:28 September 2014
Titel Quelle:Enthalten in: The journal of infectious diseases
Ort Quelle:Oxford [u.a.] : Oxford Univ. Press, 1904
Jahr Quelle:2015
Band/Heft Quelle:211(2015), 5, Seite 689-697
ISSN Quelle:1537-6613
Abstract:Background. Methylene blue (MB) has been shown to be safe and effective against falciparum malaria in Africa and to have pronounced gametocytocidal properties.Methods. Three days of treatment with artesunate (AS)-amodiaquine (AQ) combined with MB was compared with AS-AQ treatment in a randomized controlled phase IIb study; the study included 221 children aged 6-59 months with uncomplicated falciparum malaria in Burkina Faso. The primary end point was gametocyte prevalence during follow-up, as determined by microscopy and real-time quantitative nucleic acid sequence-based amplification (QT-NASBA).Results. The gametocyte prevalence of Plasmodium falciparum at baseline was 3.6% (microscopy) and 97% (QT-NASBA). It was significantly lower in the AS-AQ-MB than in the AS-AQ group on day 7 of follow-up (microscopy, 1.2% vs 8.9% [P < .05]; QT-NASBA, 36.7% vs 63.3% [P < .001]). Hemoglobin values were significantly lower in the AS-AQ-MB group than in the AS-AQ group at days 2 and 7 of follow-up. Vomiting of the study medication occurred significantly more frequently in the AS-AQ-MB group.Conclusions. The combination of MB with an artemisinin-based combination therapy has been confirmed to be effective against the gametocytes of P. falciparum. MB-based combinations need to be compared with primaquine-based combinations, preferably using MB in an improved pediatric formulation.Clinical Trials Registration. NCT01407887.
DOI:doi:10.1093/infdis/jiu540
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1093/infdis/jiu540
 DOI: https://doi.org/10.1093/infdis/jiu540
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1742497314
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68671794   QR-Code
zum Seitenanfang